Glutamine availability thus emerged as a key regulator of the balance between the pools of BCR/Abl protein-expressing and -negative CML cells endowed with stem/progenitor cell potential and capable to stand extremely low oxygen. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.